Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9456 USD | -0.46% | +6.25% | +27.78% |
Sales 2024 * | 27.08M 2.26B | Sales 2025 * | 37.2M 3.1B | Capitalization | 40.47M 3.37B |
---|---|---|---|---|---|
Net income 2024 * | -46M -3.84B | Net income 2025 * | -44M -3.67B | EV / Sales 2024 * | -0.6 x |
Net cash position 2024 * | 56.8M 4.74B | Net cash position 2025 * | 27.97M 2.33B | EV / Sales 2025 * | 0.34 x |
P/E ratio 2024 * |
-0.84
x | P/E ratio 2025 * |
-0.89
x | Employees | 193 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 75.47% |
Latest transcript on Rapid Micro Biosystems, Inc.
1 day | -0.46% | ||
1 week | +6.25% | ||
Current month | -2.52% | ||
1 month | -4.48% | ||
3 months | -2.52% | ||
6 months | -2.01% | ||
Current year | +27.78% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Spignesi
CEO | Chief Executive Officer | 55 | 01/14/01 |
Sean Wirtjes
DFI | Director of Finance/CFO | 54 | 01/18/01 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Kirk Malloy
CHM | Chairman | 58 | 14/23/14 |
Nat Ricciardi
BRD | Director/Board Member | 75 | 15/16/15 |
Director/Board Member | 54 | 01/09/01 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.9456 | -0.46% | 4,955 |
25/24/25 | 0.95 | +2.10% | 906 |
24/24/24 | 0.9305 | +0.17% | 1,317 |
23/24/23 | 0.929 | +6.65% | 23,333 |
22/24/22 | 0.871 | -2.13% | 11,202 |
Delayed Quote Nasdaq, April 27, 2024 at 02:00 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.78% | 40.47M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- RPID Stock